Nitazenes—heralding a second wave for the UK drug-related death crisis?

Adam Holland; Caroline S. Copeland; Gillian W. Shorter; Dean J. Connolly; Alice Wiseman; John Mooney; Kevin Fenton; Magdalena Harris

doi:10.1016/S2468-2667(24)00001-X

Nitazenes—heralding a second wave for the UK drug-related death crisis?

Adam Holland, Caroline S. Copeland, Gillian W. Shorter, Dean J. Connolly, Alice Wiseman, John Mooney, Kevin Fenton, Magdalena Harris

Institute of Pharmaceutical Science

Research output: Contribution to journal › Comment/debate › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	e71-e72
Journal	The Lancet Public Health
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/S2468-2667(24)00001-X
Publication status	Published - Feb 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2468-2667(24)00001-X

Cite this

@article{0b5bbe4586b9438c970567318c7c2133,

title = "Nitazenes—heralding a second wave for the UK drug-related death crisis?",

author = "Adam Holland and Copeland, {Caroline S.} and Shorter, {Gillian W.} and Connolly, {Dean J.} and Alice Wiseman and John Mooney and Kevin Fenton and Magdalena Harris",

year = "2024",

month = feb,

doi = "10.1016/S2468-2667(24)00001-X",

language = "English",

volume = "9",

pages = "e71--e72",

journal = "The Lancet Public Health",

issn = "2468-2667",